Pharma

Vertex Pharmaceuticals CEO Reshma Kewalramani Honored with the Lifetime Achievement Award 2024

November 21, 2024

Accelerating Climate Action, 11 Boston and Cambridge Institutions Collaborate to Invest in Wind and Solar Power

November 20, 2024

Lumicell’s Board of Directors Appoints Howard Hechler as Chief Executive Officer

November 13, 2024

THIS WEEK'S STORIES

Enveda Closes $130M Series C Funding to Deliver Multiple Clinical Readouts from a Pipeline of 10 Development Candidates

November 21, 2024

Faeth Therapeutics Appoints Dr. Stephen Hahn and Dr. Jayson Dallas to Board of Directors

November 22, 2024

Vertex Pharmaceuticals CEO Reshma Kewalramani Honored with the Lifetime Achievement Award 2024

November 21, 2024

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Precision BioSciences Highlights Preclinical Data and Outlines Design of First-in-Human Clinical Trial for PBGENE-HBV for Treatment of Chronic Hepatitis B

Aptar Pharma Enters into Exclusive Agreement with Cambridge Healthcare Innovations to Commercialize the Quattrii Dry Powder Inhaler Platform

Scripps Research Advances Breakthrough Regenerative Medicines to Reverse Aging-Related Diseases

Bayer and Liveo Research Launch First-of-its-Kind Blister Packaging with Improved Environmental Footprint

Lantern Pharma’s Investigational Drug-Candidate, LP-184, Receives Fast-Track Designation in Glioblastoma from the FDA

Most Read

Niterra Ventures Company Invests $18M Additional Funding in Neoplas Med GmbH

BrioHealth Solutions Begins Patient Enrollment in INNOVATE Trial of BrioVAD® System for Advanced Heart Failure

HemoSonics Honored as One of the Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500

Inspira Health Announces Promotion of Julie H. Ellis, MBA, SHRM-SCP to Senior Vice President and Chief Human Resources Officer

EDITOR PICKS

Vertex Pharmaceuticals CEO Reshma Kewalramani Honored with the Lifetime Achievement Award 2024

Accelerating Climate Action, 11 Boston and Cambridge Institutions Collaborate to Invest in Wind and Solar Power

Lumicell’s Board of Directors Appoints Howard Hechler as Chief Executive Officer

THIS WEEK'S STORIES

Enveda Closes $130M Series C Funding to Deliver Multiple Clinical Readouts from a Pipeline of 10 Development Candidates

Faeth Therapeutics Appoints Dr. Stephen Hahn and Dr. Jayson Dallas to Board of Directors

Vertex Pharmaceuticals CEO Reshma Kewalramani Honored with the Lifetime Achievement Award 2024

POPULAR CATEGORY

ABOUT US

FOLLOW US